Evidence map›Paper›PMID 25795242›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

LQT1-phenotypes in hiPSC: Are we measuring the right thing?

Torsten Christ, András Horvath, Thomas Eschenhagen

Abstract readLetterComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. From iPSC towards cardiac tissue-a road under construction.Pflugers Archiv : European journal of physiology · 2017
    Review
  9. Article
  10. Article
  11. Reply to Christ et al.: LQT1 and JLNS phenotypes in hiPSC-derived cardiomyocytes are due to KCNQ1 mutations.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Torsten ChristDepartment of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; and DZHK (German Centre for Cardiovascular Research), German Centre for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany t.christ@uke.de.
András HorvathDepartment of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; and DZHK (German Centre for Cardiovascular Research), German Centre for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
Thomas EschenhagenDepartment of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; and DZHK (German Centre for Cardiovascular Research), German Centre for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Models, BiologicalPhenotypeHumansInduced Pluripotent Stem CellsJervell-Lange Nielsen SyndromeKCNQ1 Potassium ChannelKCNQ1 Potassium Channel

Identifiers

PMID25795242
PMCPMC4413273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.